Is that for PFAS? Okay.
We share the concerns about environmental contamination and all of the issues that surround PFAS. What I think we're trying to be very cautious about is to build on the experience of other jurisdictions that have already gone down the road of doing a class-wide ban using an extremely broad definition of what a PFAS is. Bans that have been implemented have had to be walked back because people have realized that all of a sudden they were not going to have inhalational anaesthetics, and they were all of a sudden not going to have certain non-steroidal anti-inflammatories because these compounds would now fall into this very broad definition.
I think we should look at the experience of other jurisdictions and take into consideration very carefully how we define PFAS and what rationale is. Also, we must make sure.... All of our drugs and all the packaging we use in our drugs have to go through very rigorous regulatory requirements as it is, which includes their management throughout their life cycle from product inception right through to disposal of remaining product and packaging.
When we look at developing PFAS regulations in this country, we need to be very careful, I think, that we don't have unintended consequences from those bans that will then essentially really curtail our ability to have access to products, both human and veterinary, with respect to drugs and vaccines.